To assess vaccine effectiveness against medically-attended, laboratory-confirmed influenza in primary care in Europe for the 2024/25 season.
Analysis of vaccine effectiveness in a primary care network in Europe
Focus on medically-attended and laboratory-confirmed cases
Data collected from the I-MOVE primary care network under the VEBIS project
Influenza vaccination protected approximately one in two vaccinated individuals
Vaccine effectiveness varied by influenza subtype
Protection rates differed according to age group.
Abstract
Influenza vaccination protected approximately one in two vaccinated individuals against medically-attended infection in primary care in Europe, 2024/25, varying by (sub)type and age.